Eli Lilly
2,304 hedge funds and large institutions have $217B invested in Eli Lilly in 2021 Q4 according to their latest regulatory filings, with 371 funds opening new positions, 854 increasing their positions, 686 reducing their positions, and 86 closing their positions.
331% more first-time investments, than exits
New positions opened: 371 | Existing positions closed: 86
44% more funds holding in top 10
Funds holding in top 10: 55 → 79 (+24)
24% more repeat investments, than reductions
Existing positions increased: 854 | Existing positions reduced: 686
19% more capital invested
Capital invested by funds: $183B → $217B (+$34.5B)
12% more funds holding
Funds holding: 2,051 → 2,304 (+253)
0.29% less ownership
Funds ownership: 82.87% → 82.58% (-0.29%)
25% less call options, than puts
Call options by funds: $1.77B | Put options by funds: $2.37B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$932M |
| 2 |
Capital World Investors
Los Angeles,
California
|
+$590M |
| 3 |
JP Morgan Chase
New York
|
+$333M |
| 4 |
DZ Bank
Frankfurt Am Main,
Germany
|
+$319M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$275M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$1.29B |
| 2 |
Primecap Management
Pasadena,
California
|
-$763M |
| 3 |
Franklin Resources
San Mateo,
California
|
-$286M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$278M |
| 5 |
1832 Asset Management
Toronto,
Ontario, Canada
|
-$238M |
LLY Hedge Fund Activity: Q4 2021 in Review
2,304 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Eli Lilly (LLY) for Q4 2021, worth a combined $217B — up 19% from $183B a quarter earlier.
Buyers outnumbered sellers: 371 funds opened new LLY positions and 86 closed out — a net gain of 285 holders — while 854 added to existing stakes and 686 trimmed.
The largest buyer was BlackRock, adding an estimated $932M. The largest seller was T. Rowe Price Associates, cutting an estimated $1.29B.
- 2,304 institutional investors held Eli Lilly (LLY) as of Q4 2021, up from 2,051 in Q3 2021.
- Funds reported $217B of Eli Lilly stock for Q4 2021, up 19% quarter-over-quarter.
- 371 funds opened new Eli Lilly positions in Q4 2021 and 86 closed out, a net change of +285 holders.
- The largest Eli Lilly buyer in Q4 2021 was BlackRock, an estimated $932M added.
- The largest Eli Lilly seller in Q4 2021 was T. Rowe Price Associates, an estimated $1.29B sold.
Based on aggregated 13F filings for Q4 2021.